Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 3
2008 5
2009 3
2010 3
2011 2
2012 2
2013 7
2014 5
2015 9
2016 9
2017 3
2018 8
2019 3
2020 9
2021 7
2022 6
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

78 results

Results by year

Filters applied: . Clear all
Page 1
PeptiVAX: A new adaptable peptides-delivery platform for development of CTL-based, SARS-CoV-2 vaccines.
Feola S, Chiaro J, Fusciello M, Russo S, Kleino I, Ylösmäki L, Kekäläinen E, Hästbacka J, Pekkarinen PT, Ylösmäki E, Capone S, Folgori A, Raggioli A, Boni C, Tiezzi C, Vecchi A, Gelzo M, Kared H, Nardin A, Fehlings M, Barban V, Ahokas P, Viitala T, Castaldo G, Pastore L, Porter P, Pesonen S, Cerullo V. Feola S, et al. Among authors: viitala t. Int J Biol Macromol. 2024 Mar;262(Pt 1):129926. doi: 10.1016/j.ijbiomac.2024.129926. Epub 2024 Feb 6. Int J Biol Macromol. 2024. PMID: 38331062
Development of a Syrian hamster anti-PD-L1 monoclonal antibody enables oncolytic adenoviral immunotherapy modelling in an immunocompetent virus replication permissive setting.
Clubb JHA, Kudling TV, Girych M, Haybout L, Pakola S, Hamdan F, Cervera-Carrascon V, Hemmes A, Grönberg-Vähä-Koskela S, Santos JM, Quixabeira DCA, Basnet S, Heiniö C, Arias V, Jirovec E, Kaptan S, Havunen R, Sorsa S, Erikat A, Schwartz J, Anttila M, Aro K, Viitala T, Vattulainen I, Cerullo V, Kanerva A, Hemminki A. Clubb JHA, et al. Among authors: viitala t. Front Immunol. 2023 Feb 3;14:1060540. doi: 10.3389/fimmu.2023.1060540. eCollection 2023. Front Immunol. 2023. PMID: 36817448 Free PMC article.
An oomycete NLP cytolysin forms transient small pores in lipid membranes.
Pirc K, Clifton LA, Yilmaz N, Saltalamacchia A, Mally M, Snoj T, Žnidaršič N, Srnko M, Borišek J, Parkkila P, Albert I, Podobnik M, Numata K, Nürnberger T, Viitala T, Derganc J, Magistrato A, Lakey JH, Anderluh G. Pirc K, et al. Among authors: viitala t. Sci Adv. 2022 Mar 11;8(10):eabj9406. doi: 10.1126/sciadv.abj9406. Epub 2022 Mar 11. Sci Adv. 2022. PMID: 35275729 Free PMC article.
Assembly of Bleomycin Saccharide-Decorated Spherical Nucleic Acids.
Tähtinen V, Gulumkar V, Maity SK, Yliperttula AM, Siekkinen S, Laine T, Lisitsyna E, Haapalehto I, Viitala T, Vuorimaa-Laukkanen E, Yliperttula M, Virta P. Tähtinen V, et al. Among authors: viitala t. Bioconjug Chem. 2022 Jan 19;33(1):206-218. doi: 10.1021/acs.bioconjchem.1c00539. Epub 2022 Jan 5. Bioconjug Chem. 2022. PMID: 34985282 Free PMC article.
Neonatal Fc receptor-targeted lignin-encapsulated porous silicon nanoparticles for enhanced cellular interactions and insulin permeation across the intestinal epithelium.
Martins JP, Figueiredo P, Wang S, Espo E, Celi E, Martins B, Kemell M, Moslova K, Mäkilä E, Salonen J, Kostiainen MA, Celia C, Cerullo V, Viitala T, Sarmento B, Hirvonen J, Santos HA. Martins JP, et al. Among authors: viitala t. Bioact Mater. 2021 Aug 10;9:299-315. doi: 10.1016/j.bioactmat.2021.08.007. eCollection 2022 Mar. Bioact Mater. 2021. PMID: 34820572 Free PMC article.
78 results